{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:31:25Z","timestamp":1777984285785,"version":"3.51.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","award":["No. LHGJ20190567"],"award-info":[{"award-number":["No. LHGJ20190567"]}],"id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04212-7","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T12:34:09Z","timestamp":1769949249000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identify the PANoptosis signature and prognostic model via a multimachine-learning computational framework for bladder urothelial carcinoma"],"prefix":"10.1186","volume":"26","author":[{"given":"Shiyong","family":"Xin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianchao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingshuai","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wangli","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,1]]},"reference":[{"issue":"1","key":"4212_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025;75(1):10\u201345.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4212_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41585-018-0105-y","volume":"16","author":"B Jordan","year":"2019","unstructured":"Jordan B, Meeks JJ. T1 bladder cancer: current considerations for diagnosis and management. Nat Rev Urol. 2019;16(1):23\u201334.","journal-title":"Nat Rev Urol"},{"issue":"3","key":"4212_CR3","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","volume":"56","author":"BW van Rhijn","year":"2009","unstructured":"van Rhijn BW, Burger M, Lotan Y, et al. Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol. 2009;56(3):430\u201342.","journal-title":"Eur Urol"},{"issue":"1","key":"4212_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","volume":"69","author":"S Cambier","year":"2016","unstructured":"Cambier S, Sylvester RJ, Collette L, et al. EORTC nomograms and risk groups for predicting Recurrence, Progression, and Disease-specific and overall survival in Non-Muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1\u20133 years of maintenance Bacillus Calmette-Gu\u00e9rin. Eur Urol. 2016;69(1):60\u20139.","journal-title":"Eur Urol"},{"issue":"8","key":"4212_CR5","first-page":"769","volume":"57","author":"A Peyrottes","year":"2021","unstructured":"Peyrottes A, Ouzaid I, Califano G, Hermieu JF, Xylinas E. Neoadjuvant immunotherapy for muscle-invasive bladder cancer. Med Kaunas. 2021;57(8):769.","journal-title":"Med Kaunas"},{"issue":"4","key":"4212_CR6","doi-asserted-by":"publisher","first-page":"4799","DOI":"10.1002\/jcp.27279","volume":"234","author":"Z Tian","year":"2019","unstructured":"Tian Z, Cao S, Li C, et al. LncRNA PVT1 regulates growth, migration, and invasion of bladder cancer by miR-31\/ CDK1. J Cell Physiol. 2019;234(4):4799\u2013811.","journal-title":"J Cell Physiol"},{"key":"4212_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.847345","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J, Hong M, Li Y, Chen D, Wu Y, Hu Y. Programmed cell death tunes tumour immunity. Front Immunol. 2022;13:847345.","journal-title":"Front Immunol"},{"key":"4212_CR8","unstructured":"Yu Y, You Y, Duan Y et al. Multi-omics approaches for identifying the PANoptosis signature and prognostic model via a multimachine-learning computational framework for intrahepatic cholangiocarcinoma. Hepatology."},{"issue":"12","key":"4212_CR9","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. Consensusclusterplus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"issue":"1","key":"4212_CR10","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1021\/acs.jproteome.7b00595","volume":"17","author":"FM Alakwaa","year":"2018","unstructured":"Alakwaa FM, Chaudhary K, Garmire LX. Deep learning accurately predicts Estrogen receptor status in breast cancer metabolomics data. J Proteome Res. 2018;17(1):337\u201347.","journal-title":"J Proteome Res"},{"key":"4212_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1878766","volume":"2022","author":"LH Qu","year":"2022","unstructured":"Qu LH, Luo WJ, Yan ZG, Liu WP. FAM171B as a novel biomarker mediates tissue immune microenvironment in pulmonary arterial hypertension. Mediators Inflamm. 2022;2022:1878766.","journal-title":"Mediators Inflamm"},{"issue":"2","key":"4212_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.artmed.2013.12.001","volume":"60","author":"Y Nakano","year":"2014","unstructured":"Nakano Y, Takeshita T, Kamio N, et al. Supervised machine learning-based classification of oral Malodor based on the microbiota in saliva samples. Artif Intell Med. 2014;60(2):97\u2013101.","journal-title":"Artif Intell Med"},{"key":"4212_CR13","doi-asserted-by":"crossref","unstructured":"Park SY. Nomogram: an analogue tool to deliver digital knowledge. J Thorac Cardiovasc Surg. 2018;155(4):1793.","DOI":"10.1016\/j.jtcvs.2017.12.107"},{"issue":"5","key":"4212_CR14","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/modpathol.2011.191","volume":"25","author":"YT Chung","year":"2012","unstructured":"Chung YT, Matkowskyj KA, Li H, et al. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma. Mod Pathol. 2012;25(5):758\u201366.","journal-title":"Mod Pathol"},{"issue":"1","key":"4212_CR15","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1038\/s41467-018-07767-w","volume":"9","author":"Q Jia","year":"2018","unstructured":"Jia Q, Wu W, Wang Y, et al. Local mutational diversity drives intratumoural immune heterogeneity in non-small cell lung cancer. Nat Commun. 2018;9(1):5361.","journal-title":"Nat Commun"},{"key":"4212_CR16","doi-asserted-by":"publisher","unstructured":"Barnes TA, Amir E. HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer. Br J Cancer. 2018;118(2):e5. https:\/\/doi.org\/10.1038\/bjc.2017.417. Epub 2018 Jan 9. Erratum for: Br J Cancer. 2017;117(4):451\u2013460.","DOI":"10.1038\/bjc.2017.417"},{"issue":"4","key":"4212_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","volume":"12","author":"WH Fridman","year":"2012","unstructured":"Fridman WH, Pag\u00e8s F, Saut\u00e8s-Fridman C, Galon J. The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer. 2012;12(4):298\u2013306.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"4212_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran L, Xiao JF, Agarwal N, Duex JE, Theodorescu D. Advances in bladder cancer biology and therapy. Nat Rev Cancer. 2021;21(2):104\u201321.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"4212_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41571-020-0333-y","volume":"17","author":"A Byrne","year":"2020","unstructured":"Byrne A, Savas P, Sant S, Li R, Virassamy B, Luen SJ, et al. Tissue-resident memory t cells in breast cancer control and immunotherapy responses. Nat Rev Clin Oncol. 2020;17(6):341\u20138.","journal-title":"Nat Rev Clin Oncol"},{"key":"4212_CR20","doi-asserted-by":"publisher","first-page":"900108","DOI":"10.3389\/fonc.2022.900108","volume":"12","author":"G Xiong","year":"2022","unstructured":"Xiong G, Ouyang S, Xie N, et al. FOSL1 promotes tumour growth and invasion in ameloblastoma. Front Oncol. 2022;12:900108.","journal-title":"Front Oncol"},{"issue":"8","key":"4212_CR21","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1016\/j.ymthe.2021.03.024","volume":"29","author":"M Zhang","year":"2021","unstructured":"Zhang M, Hoyle RG, Ma Z, et al. FOSL1 promotes metastasis of head and neck squamous cell carcinoma through super-enhancer-driven transcription program. Mol Ther. 2021;29(8):2583\u2013600.","journal-title":"Mol Ther"},{"issue":"16","key":"4212_CR22","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.21037\/atm-20-5492","volume":"8","author":"S Hu","year":"2020","unstructured":"Hu S, Chen Z, Gu J, Tan L, Zhang M, Lin W. TLE2 is associated with favorable prognosis and regulates cell growth and gemcitabine sensitivity in pancreatic cancer. Ann Transl Med. 2020;8(16):1017.","journal-title":"Ann Transl Med"},{"issue":"12","key":"4212_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11121840","volume":"11","author":"S Wu","year":"2019","unstructured":"Wu S, Nitschke K, Heinkele J, et al. ANLN and TLE2 in muscle invasive bladder cancer: a functional and clinical evaluation based on in silico and in vitro data. Cancers (Basel). 2019;11(12):1840.","journal-title":"Cancers (Basel)"},{"key":"4212_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108458","volume":"247","author":"F Liu","year":"2023","unstructured":"Liu F, Wu Q, Dong Z, Liu K. Integrins in cancer: emerging mechanisms and therapeutic opportunities. Pharmacol Ther. 2023;247:108458.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"4212_CR25","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2483379","volume":"57","author":"Y Lan","year":"2025","unstructured":"Lan Y, Liu D, Liang B, et al. ITGA3-MET interaction promotes papillary thyroid cancer progression via ERK and PI3K\/AKT pathways. Ann Med. 2025;57(1):2483379.","journal-title":"Ann Med"},{"key":"4212_CR26","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.2147\/OTT.S201675","volume":"12","author":"Y Jiao","year":"2019","unstructured":"Jiao Y, Li Y, Liu S, Chen Q, Liu Y. ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer. Onco Targets Ther. 2019;12:4141\u201352.","journal-title":"Onco Targets Ther"},{"issue":"8","key":"4212_CR27","doi-asserted-by":"publisher","first-page":"3814","DOI":"10.3390\/ijms22083814","volume":"22","author":"TC Lin","year":"2021","unstructured":"Lin TC. Functional roles of SPINK1 in cancers. Int J Mol Sci. 2021;22(8):3814.","journal-title":"Int J Mol Sci"},{"key":"4212_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.938470","author":"X Zhou","year":"2022","unstructured":"Zhou X, Khan S, Huang D, et al. V-set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.938470.","journal-title":"Front Immunol"},{"key":"4212_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jbiotec.2017.08.023","volume":"260","author":"W Yang","year":"2017","unstructured":"Yang W, Padkj\u00e6r SB, Wang J, et al. Construction of a versatile expression library for all human single-pass transmembrane proteins for receptor pairings by high throughput screening. J Biotechnol. 2017;260:18\u201330.","journal-title":"J Biotechnol"},{"key":"4212_CR30","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.2147\/CMAR.S316584","volume":"13","author":"Z Cui","year":"2021","unstructured":"Cui Z, Li Y, He S, et al. Key candidate genes - VSIG2 of colon cancer identified by weighted gene Co-Expression network analysis. Cancer Manag Res. 2021;13:5739\u201350.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"4212_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01209-x","volume":"21","author":"J Xu","year":"2023","unstructured":"Xu J, Quan G, Huang W, Jiang J. VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation. Cell Commun Signal. 2023;21(1):223.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"4212_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02782-y","volume":"16","author":"M Yuan","year":"2025","unstructured":"Yuan M, Li X, Song X, et al. Lactate metabolism-related genes serve as potential biomarkers for predicting gastric cancer progression and immunotherapy. Discov Oncol. 2025;16(1):1012.","journal-title":"Discov Oncol"},{"issue":"6","key":"4212_CR33","doi-asserted-by":"publisher","first-page":"e0302022","DOI":"10.1128\/mbio.03020-22","volume":"13","author":"P Thakur","year":"2022","unstructured":"Thakur P, Sutiwisesak R, Lu YJ, Behar SM. Use of the human granulysin transgenic mice to evaluate the role of granulysin expression by CD8 T cells in immunity to Mycobacterium tuberculosis. mBio. 2022;13(6):e0302022.","journal-title":"mBio"},{"issue":"12","key":"4212_CR34","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng H, Huang F, Yu Z, et al. The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022;40(12):1566-1582.e10.","journal-title":"Cancer Cell"},{"issue":"1","key":"4212_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12935-021-01799-x","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang J, Chen L, Qiang P. The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers. Cancer Cell Int. 2021;21(1):99.","journal-title":"Cancer Cell Int"},{"key":"4212_CR36","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.ccell.2022.10.011","volume":"40","author":"M Han","year":"2022","unstructured":"Han M, Li F, Zhang Y, Dai P, He J, Li Y, et al. FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer. Cancer Cell. 2022;40:1306\u2013e238.","journal-title":"Cancer Cell"},{"key":"4212_CR37","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41586-019-1318-9","volume":"571","author":"E Adams","year":"2019","unstructured":"Adams E, Karthaus W, Hoover E, Liu D, Gruet A, Zhang Z, et al. FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes. Nature. 2019;571:408\u201312.","journal-title":"Nature"},{"key":"4212_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22139-7","volume":"12","author":"S Baca","year":"2021","unstructured":"Baca S, Takeda D, Seo J, Hwang J, Ku S, Arafeh R, et al. Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer. Nat Commun. 2021;12:1979.","journal-title":"Nat Commun"},{"key":"4212_CR39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI122367","author":"B Song","year":"2019","unstructured":"Song B, Park S, Zhao J, Fong K, Li S, Lee Y, et al. Targeting FOXA1-mediated repression of TGF-\u03b2 signaling suppresses castration-resistant prostate cancer progression. J Clin Invest. 2019. https:\/\/doi.org\/10.1172\/JCI122367.","journal-title":"J Clin Invest"},{"key":"4212_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3727\/096504018X15201058168730","volume":"27","author":"X Chen","year":"2019","unstructured":"Chen X, Li M, Zhou H, Zhang L. MiR-132 targets FOXA1 and exerts tumour-suppressing functions in thyroid cancer. Oncol Res. 2019;27:431\u20137.","journal-title":"Oncol Res"},{"key":"4212_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2017.11.023","author":"M Lin","year":"2018","unstructured":"Lin M, Pan J, Chen Q, Xu Z, Lin X, Shi C. Overexpression of FOXA1 inhibits cell proliferation and EMT of human gastric cancer AGS cells. Gene. 2018. https:\/\/doi.org\/10.1016\/j.gene.2017.11.023.","journal-title":"Gene"},{"issue":"5","key":"4212_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41422-019-0164-5","volume":"29","author":"D Tang","year":"2019","unstructured":"Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29(5):347\u201364.","journal-title":"Cell Res"},{"issue":"4","key":"4212_CR43","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4212_CR44","first-page":"10","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, Zhang G, Xu P, et al. Optimized dynamic network biomarker deciphers a high-resolution heterogeneity within thyroid cancer molecular subtypes. Med Res. 2025;1:10-31.","journal-title":"Med Res"},{"key":"4212_CR45","first-page":"397","volume":"1","author":"X Ke","year":"2025","unstructured":"Ke X, Li K, Jiang A, et al. Cloud-based GWAS platform: an innovative solution for efficient acquisition and analysis of genomic data. Med Res. 2025;1:397 -411.","journal-title":"Med Res"},{"key":"4212_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105880","volume":"76","author":"L Sharifi","year":"2019","unstructured":"Sharifi L, Nowroozi MR, Amini E, Arami MK, Ayati M, Mohsenzadegan M. A review on the role of M2 macrophages in bladder cancer; pathophysiology and targeting. Int Immunopharmacol. 2019;76:105880.","journal-title":"Int Immunopharmacol"},{"key":"4212_CR47","doi-asserted-by":"publisher","first-page":"1056932","DOI":"10.3389\/fimmu.2022.1056932","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Qin D, Tao Z, et al. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumour microenvironment landscape in gastric cancer. Front Immunol. 2022;13:1056932. Published 2022 Nov 21.","journal-title":"Front Immunol"},{"issue":"10","key":"4212_CR48","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41585-019-0226-y","volume":"16","author":"AK Schneider","year":"2019","unstructured":"Schneider AK, Chevalier MF, Derr\u00e9 L. The multifaceted immune regulation of bladder cancer. Nat Rev Urol. 2019;16(10):613\u201330.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"4212_CR49","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41568-019-0235-4","volume":"20","author":"AM van der Leun","year":"2020","unstructured":"van der Leun AM, Thommen DS, Schumacher TN. CD8\u2009+\u2009T cell states in human cancer: insights from single-cell analysis. Nat Rev Cancer. 2020;20(4):218\u201332.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"4212_CR50","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s13402-019-00453-z","volume":"42","author":"A Salmaninejad","year":"2019","unstructured":"Salmaninejad A, Valilou SF, Soltani A, et al. Tumor-associated macrophages: role in cancer development and therapeutic implications. Cell Oncol (Dordr). 2019;42(5):591\u2013608. https:\/\/doi.org\/10.1007\/s13402-019-00453-z.","journal-title":"Cell Oncol (Dordr)"},{"issue":"6","key":"4212_CR51","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41419-019-1618-x","volume":"10","author":"Z Guo","year":"2019","unstructured":"Guo Z, Song J, Hao J, et al. M2 macrophages promote NSCLC metastasis by upregulating CRYAB. Cell Death Dis. 2019;10(6):377. Published 2019 May 16.","journal-title":"Cell Death Dis"},{"issue":"11","key":"4212_CR52","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1158\/2326-6066.CIR-20-0123","volume":"8","author":"J Qin","year":"2020","unstructured":"Qin J, Zhang X, Tan B, et al. Blocking P2X7-mediated macrophage polarization overcomes treatment resistance in lung cancer. Cancer Immunol Res. 2020;8(11):1426\u201339.","journal-title":"Cancer Immunol Res"},{"issue":"11","key":"4212_CR53","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/s41577-021-00537-8","volume":"21","author":"M Reina-Campos","year":"2021","unstructured":"Reina-Campos M, Scharping NE, Goldrath AW. CD8\u2009+\u2009T cell metabolism in infection and cancer. Nat Rev Immunol. 2021;21(11):718\u201338.","journal-title":"Nat Rev Immunol"},{"key":"4212_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1476904","volume":"15","author":"B Zhang","year":"2024","unstructured":"Zhang B, Liu J, Mo Y, Zhang K, Huang B, Shang D. CD8\u2009+\u2009T cell exhaustion and its regulatory mechanisms in the tumour microenvironment: key to the success of immunotherapy. Front Immunol. 2024;15:1476904.","journal-title":"Front Immunol"},{"issue":"10","key":"4212_CR55","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"key":"4212_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.938470","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Khan S, Huang D, et al. V-set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy. Front Immunol. 2022;13:938470.","journal-title":"Front Immunol"},{"key":"4212_CR57","doi-asserted-by":"crossref","unstructured":"Zhang P, Zhang M, Liu J, et al. Mitochondrial Pathway Signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J Immunother Cancer. 2025;13(7):e012069.","DOI":"10.1136\/jitc-2025-012069"},{"issue":"7","key":"4212_CR58","doi-asserted-by":"publisher","first-page":"e012069","DOI":"10.1136\/jitc-2025-012069","volume":"13","author":"P Zhang","year":"2025","unstructured":"Zhang P, Zhang M, Liu J, et al. Mitochondrial pathway signature (MitoPS) predicts immunotherapy response and reveals NDUFB10 as a key immune regulator in lung adenocarcinoma. J Immunother Cancer. 2025;13(7):e012069.","journal-title":"J Immunother Cancer"},{"issue":"39","key":"4212_CR59","doi-asserted-by":"publisher","first-page":"eadp2442","DOI":"10.1126\/sciadv.adp2442","volume":"10","author":"S Artham","year":"2024","unstructured":"Artham S, Juras PK, Goyal A, et al. Estrogen signaling suppresses tumour-associated tissue eosinophilia to promote breast tumour growth. Sci Adv. 2024;10(39):eadp2442.","journal-title":"Sci Adv"},{"issue":"2","key":"4212_CR60","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1515\/HMBCI.2010.075","volume":"5","author":"CA Lamartiniere","year":"2011","unstructured":"Lamartiniere CA, Jenkins S, Betancourt AM, Wang J, Russo J. Exposure to the endocrine disruptor bisphenol A alters susceptibility for mammary cancer. Horm Mol Biol Clin Investig. 2011;5(2):45\u201352.","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"3\u20134","key":"4212_CR61","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/10937400701876095","volume":"11","author":"F Salehi","year":"2008","unstructured":"Salehi F, Dunfield L, Phillips KP, Krewski D, Vanderhyden BC. Risk factors for ovarian cancer: an overview with emphasis on hormonal factors. J Toxicol Environ Health B Crit Rev. 2008;11(3\u20134):301\u201321.","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"4212_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109604","volume":"121","author":"SM Tang","year":"2020","unstructured":"Tang SM, Deng XT, Zhou J, Li QP, Ge XX, Miao L. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed Pharmacother. 2020;121:109604.","journal-title":"Biomed Pharmacother"},{"key":"4212_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.139468","volume":"297","author":"M Li","year":"2025","unstructured":"Li M, Cui Y, Wu X, et al. Integrating network pharmacology to investigate the mechanism of quercetin\u2019s action through AKT inhibition in co-expressed genes associated with polycystic ovary syndrome and endometrial cancer. Int J Biol Macromol. 2025;297:139468.","journal-title":"Int J Biol Macromol"},{"issue":"9","key":"4212_CR64","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/1759-7714.13925","volume":"12","author":"H Guo","year":"2021","unstructured":"Guo H, Ding H, Tang X, et al. Quercetin induces pro-apoptotic autophagy via SIRT1\/AMPK signaling pathway in human lung cancer cell lines A549 and H1299 in vitro. Thorac Cancer. 2021;12(9):1415\u201322.","journal-title":"Thorac Cancer"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04212-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04212-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04212-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T11:46:31Z","timestamp":1772451991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04212-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4212"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04212-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7705646\/v1","asserted-by":"object"}]},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study complied with the principles set forth in the Declaration of Helsinki. Access to the de-identified linked dataset was obtained from the TCGA databases in accordance with the database policy. For analyses of de-identified data from the TCGA databases, institutional review board approval and informed consent were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the final version of the manuscript and agree.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}